FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

El Sayed mocks Rogers’s ‘earpiece’ and Trump’s ‘a**’ remarks in Grand Rapids rally

Sanders calls Michigan Senate race a test of Trump, accuses president of using racism to divide voters

Bruce Blakeman calls Kathy Hochul Zohran Mamdani’s ‘puppet’ during New York campaign rally

College homecoming party turns to chaos as deck collapses, leaving at least 28 people injured

Ninth Circuit questions Trump DOJ’s emergency request to set aside 20,000 California mail ballots

Stolen car slams into South Carolina home as teens bolt, authorities say

Woman busted in NYC rabbi syringe attack allegedly stabbed another Jewish man hours earlier: report

Ilhan Omar Accused of Leaking Info to Foreign Leaders in Somalia as Resurfaced Post Brings Evidence to Light

Airbnb Cracks Down on Hosts Treating Guests Like a Free Maid Service

How Is This Legal? Pollster Boosting Dem in Mississippi Admits It Fabricated Most Election Surveys

MAPPED: The states Trump and top Democrats are targeting before Election Day

Young Voters Who Helped Hand Trump White House Are Flocking Back to Dems for the Midterms: Poll

‘Pay the Community’: Trump Pushes Builders to Give Local Americans Extra Payday to Put Up with Unpopular Data Centers

5 victims released from hospital after Florida A&M University shooting, 1 remains critical

‘Nothing Compared to What Is Coming’: Bukele Issues Stark Warning to Haitian Gangs

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”